What is the core agreement between SciDev and Newmont?

SciDev (ASX:SDV) has executed a three-year contract to supply MaxiFlox chemistry and OptiFlox dose control technology to Newmont (ASX:NEM) at its Boddington Gold Operations in Western Australia.

What is the financial layout and expected revenue of the agreement?

SciDev (ASX:SDV) forecasts the contract will generate approximately $6 million in total sales over the initial three-year term. The company expects sales to generate roughly $2 million in revenue per annum.

What are the pipeline timelines for the contract delivery?

SciDev (ASX:SDV) expects commercial sales under the agreement to begin in early H1 FY27. Deliveries will continue on an ongoing basis across the initial three-year duration of the contract.

How did the market react to the SciDev corporate announcement?

Following the contract disclosure, the SciDev (ASX:SDV) share price increased to $0.135. This market movement followed the public release of the contract details with Newmont (ASX:NEM).

What geographic and project location is impacted by this deal?

SciDev (ASX:SDV) will deliver its services directly to the Boddington Gold Operations owned by Newmont (ASX:NEM), located 130km southeast of Perth, Western Australia.

Tech

Image for illustrative purposes only. Not a real photo.

SciDev secures $6M Newmont chemistry contract

Written by Isaac FrancisPublished Jun 23, 2026, 6:15 AM

SciDev has secured a three-year agreement with gold and copper miner Newmont.
The company's share price increased following the contract disclosure.
The transaction aligns with the business strategy to grow long-term recurring revenue.

SciDev (ASX:SDV) has executed a three-year contract valued at approximately $6 million to supply chemistry and dose control technology to Newmont's (ASX:NEM) Boddington Gold Operations in Western Australia.

The newly executed agreement follows a period where external market disruptions required the business to adjust its historical revenue outlook.

"Securing a multi-year contract with an operator of Newmont's calibre is a significant endorsement of our chemistry and dose control technology," said SciDev CEO Todd Scott.

The company stated that sales are expected to begin in early H1 FY27 and are anticipated to generate approximately $2.0 million in revenues per annum over the duration of the contract.

Following the announcement, the SciDev share price was up at $0.135.

The company's Process Chemistry business focuses on developing a range of flocculant chemistries to enhance metal extraction, recover water, and improve operational efficiencies for clients.

The technology implementation also targets the mining company's goal to improve the overall stability of its earnings base.

SciDev secures $6M Newmont chemistry contract

Frequently asked questions

Assets related to this article